logo
logo

Aerobiotix Raises $25M Growth Equity Financing Led By Global Healthcare Investment Firm Vivo Capital

May 06, 2021•over 4 years ago

Amount Raised

$25 Million

Miamisburg

Description

Founded in 2013, Aerobiotix, a rapidly growing global medical company has raised a $25 million of growth equity financing. The round was led by Vivo Capital with participation by Asahi Kasei Ventures. The new funding will be used to accelerate sales, marketing, and new product development. The Company’s infection control products have been used to support thousands of procedures across multiple surgical specialty disciplines and in over 175 hospitals and multiple long-term care facilities.

Company Information

Company

Aerobiotix

Location

Miamisburg, Ohio, United States

About

Aerobiotix is a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long term care and office based settings. Recognizing that healthcare doesn’t stop at the patient, we drive novel technologies to optimize environments of care for patients and healthcare stakeholders. Aerobiotix’s mission is to provide airborne infection control solutions leveraging peer-reviewed science and providing its customers both daily protection as well as robust monitoring data to further inform and assist their infection control programs. More information can be found at www.aerobiotix.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech